SCHEMBL28850677

SCHEMBL28850677

CCOC(=O)Cn1cccc1C=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.53
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
KDM4E B2RXH2 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
POLB P06746 1/20 0.42
PIN1 Q13526 1/20 0.42
PIN4 Q9Y237 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
TRIM24 O15164 1/20 0.41
TRIM33 Q9UPN9 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28625554 0.84 ALDH1A1 (0.50) ALDH1A1MAPTKDM4EL3MBTL1POLB
SCHEMBL2237187 0.79 ALDH1A1 (0.50) ALDH1A1MAPTLMNAGSK3AGSK3B
SCHEMBL19964926 0.78 TRIM24 (0.47) ALDH1A1MAPTLMNAL3MBTL1MEN1
SCHEMBL28331384 0.76 TRIM24 (0.48) ALDH1A1MAPTLMNAL3MBTL1MEN1
SCHEMBL8772644 0.76 ALDH1A1 (0.50) ALDH1A1MAPTLMNAKDM4EL3MBTL1
SCHEMBL2831481 0.76 ALDH1A1 (0.52) ALDH1A1MAPTLMNAGSK3AGSK3B
SCHEMBL1126803 0.76 ALDH1A1 (0.54) ALDH1A1MAPTLMNAKDM4EL3MBTL1
SCHEMBL8377839 0.76 ALDH1A1 (0.45) ALDH1A1MAPTLMNAKDM4EMEN1
SCHEMBL5180011 0.75 ALDH1A1 (0.51) ALDH1A1MAPTLMNAGSK3AGSK3B
SCHEMBL29295631 0.75 ALDH1A1 (0.43) ALDH1A1MAPTLMNAPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109715634-B Fused bicyclic inhibitors of MENIN-MLL interaction 詹森药业有限公司 2022-09-27 CN disclosed